CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis
Muhammad Noman Khan(Dalian Medical University), Han Liu(Xi'an Jiaotong University)
Cited by 74
Related Papers
Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects
|Journal of Experimental & Clinical Cancer Research|2018|172
Cholesterol content in cell membrane maintains surface levels of ErbB2 and confers a therapeutic vulnerability in ErbB2-positive breast cancer
|Cell Communication and Signaling|2019|128
Prognostic significance of synergistic hexokinase-2 and beta2-adrenergic receptor expression in human hepatocelluar carcinoma after curative resection
|BMC Gastroenterology|2016|66
Control of fibroblast shape in sequentially formed 3D hybrid hydrogels regulates cellular responses to microenvironmental cues
|NPG Asia Materials|2020|41
Evodiamine sensitizes U87 glioblastoma cells to TRAIL via the death receptor pathway
|Molecular Medicine Reports|2014|39